Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pra Health Sciences, Inc. (PRAH) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pra Health Sciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1613859.
Total stock buying since 2016: $0.
Total stock sales since 2016: $5,665,661,239.
Total stock option exercises since 2016: $18,406,510.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 0 | $0 | 312,542 | $52,366,307 | 286,263 | $8,355,496 |
| 2020 | 0 | $0 | 46,533 | $5,307,896 | 33,372 | $391,453 |
| 2019 | 0 | $0 | 13,333,368 | $1,298,803,376 | 0 | $0 |
| 2018 | 0 | $0 | 13,067,000 | $1,319,187,470 | 67,000 | $785,910 |
| 2017 | 0 | $0 | 20,009,540 | $1,493,734,041 | 1,004,425 | $7,467,880 |
| 2016 | 0 | $0 | 30,119,751 | $1,496,262,149 | 478,154 | $1,405,771 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-06 | 0 | $0 | 309,406 | $51,958,502 | 286,263 | $8,355,496 |
| 2021-01 | 0 | $0 | 3,136 | $407,805 | 0 | $0 |
| 2020-12 | 0 | $0 | 33,372 | $4,008,644 | 33,372 | $391,453 |
| 2020-08 | 0 | $0 | 9,489 | $976,227 | 0 | $0 |
| 2020-04 | 0 | $0 | 3,672 | $323,025 | 0 | $0 |
| 2019-09 | 0 | $0 | 13,333,368 | $1,298,803,376 | 0 | $0 |
| 2018-08 | 0 | $0 | 13,000,000 | $1,313,130,000 | 0 | $0 |
| 2018-01 | 0 | $0 | 67,000 | $6,057,470 | 67,000 | $785,910 |
| 2017-12 | 0 | $0 | 72,850 | $6,630,442 | 72,850 | $854,530 |
| 2017-11 | 0 | $0 | 5,115 | $408,688 | 0 | $0 |
| 2017-08 | 0 | $0 | 19,500,000 | $1,459,574,998 | 500,000 | $4,107,000 |
| 2017-04 | 0 | $0 | 196,393 | $12,488,630 | 196,393 | $1,440,542 |
| 2017-03 | 0 | $0 | 135,182 | $8,481,284 | 135,182 | $771,809 |
| 2017-02 | 0 | $0 | 100,000 | $6,149,999 | 100,000 | $293,999 |
| 2016-11 | 0 | $0 | 15,000,000 | $832,650,000 | 0 | $0 |
| 2016-08 | 0 | $0 | 289,770 | $14,697,154 | 303,464 | $892,183 |
| 2016-05 | 0 | $0 | 5,000,000 | $233,499,999 | 92,308 | $271,385 |
| 2016-03 | 0 | $0 | 9,829,981 | $415,414,996 | 82,382 | $242,203 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-16 | Bonello Michael J. (EVP & CFO) | Sale | 17,216 | 166.95 | 2,874,211 |
| 2021-06-16 | Bonello Michael J. (EVP & CFO) | Option Ex | 17,216 | 81.61 | 1,404,997 |
| 2021-06-16 | Gaenzle Christopher L (EVP, CAO & General Counsel) | Sale | 14,278 | 166.99 | 2,384,211 |
| 2021-06-16 | Gaenzle Christopher L (EVP, CAO & General Counsel) | Option Ex | 14,278 | 100.22 | 1,430,941 |
| 2021-06-16 | Shannon Colin (President & CEO) | Sale | 88,045 | 166.97 | 14,700,433 |
| 2021-06-16 | Shannon Colin (President & CEO) | Option Ex | 88,045 | 11.73 | 1,032,767 |
| 2021-06-15 | Bonello Michael J. (EVP & CFO) | Sale | 31,126 | 168.53 | 5,245,820 |
| 2021-06-15 | Bonello Michael J. (EVP & CFO) | Option Ex | 21,123 | 78.71 | 1,662,591 |
| 2021-06-15 | Gaenzle Christopher L (EVP, CAO & General Counsel) | Sale | 14,588 | 168.55 | 2,458,807 |
| 2021-06-15 | Gaenzle Christopher L (EVP, CAO & General Counsel) | Option Ex | 12,615 | 100.22 | 1,264,275 |
| 2021-06-15 | Shannon Colin (President & CEO) | Sale | 143,303 | 168.53 | 24,150,138 |
| 2021-06-15 | Shannon Colin (President & CEO) | Option Ex | 132,986 | 11.73 | 1,559,925 |
| 2021-06-01 | Gaenzle Christopher L (EVP, CAO & General Counsel) | Sale | 850 | 170.45 | 144,882 |
| 2021-01-08 | Gaenzle Christopher L (EVP, CAO & General Counsel) | Sale | 3,136 | 130.04 | 407,805 |
| 2020-12-17 | Bonello Michael J. (EVP & CFO) | Sale | 33,372 | 120.12 | 4,008,644 |
| 2020-12-17 | Bonello Michael J. (EVP & CFO) | Option Ex | 33,372 | 11.73 | 391,453 |
| 2020-08-13 | Bonello Michael J. (EVP & CFO) | Sale | 2,052 | 102.88 | 211,109 |
| 2020-08-13 | Gaenzle Christopher L (EVP, CAO & General Counsel) | Sale | 1,364 | 102.88 | 140,328 |
| 2020-08-13 | Shannon Colin (President & CEO) | Sale | 6,073 | 102.88 | 624,790 |
| 2020-04-27 | Bonello Michael J. (EVP & CFO) | Sale | 3,672 | 87.97 | 323,025 |
| 2019-09-06 | Kkr Group Holdings Corp. | Sale | 6,666,684 | 97.41 | 649,401,688 |
| 2019-09-06 | Kkr North America Xi Ltd | Sale | 6,666,684 | 97.41 | 649,401,688 |
| 2018-08-09 | Kkr North America Xi Ltd | Sale | 6,500,000 | 101.01 | 656,565,000 |
| 2018-08-09 | Roberts George R | Sale | 6,500,000 | 101.01 | 656,565,000 |
| 2018-01-16 | Baddour Linda (Executive VP & CFO) | Sale | 67,000 | 90.41 | 6,057,470 |
| 2018-01-16 | Baddour Linda (Executive VP & CFO) | Option Ex | 67,000 | 11.73 | 785,910 |
| 2017-12-28 | Dockhorn David W (Executive Vice President & CCO) | Sale | 72,850 | 91.02 | 6,630,442 |
| 2017-12-28 | Dockhorn David W (Executive Vice President & CCO) | Option Ex | 72,850 | 11.73 | 854,530 |
| 2017-11-16 | Young Matthew P. (Director) | Sale | 5,115 | 79.90 | 408,688 |
| 2017-08-14 | Kkr North America Xi Ltd | Sale | 9,500,000 | 74.85 | 711,075,000 |
| 2017-08-14 | Shannon Colin (President & CEO) | Sale | 400,000 | 74.85 | 29,939,999 |
| 2017-08-14 | Baddour Linda (Executive VP & CFO) | Sale | 100,000 | 74.85 | 7,484,999 |
| 2017-08-14 | Roberts George R | Sale | 9,500,000 | 74.85 | 711,075,000 |
| 2017-08-08 | Shannon Colin (President & CEO) | Option Ex | 400,000 | 7.33 | 2,934,000 |
| 2017-08-08 | Baddour Linda (Executive VP & CFO) | Option Ex | 100,000 | 11.73 | 1,173,000 |
| 2017-04-17 | Baddour Linda (Executive VP & CFO) | Sale | 196,393 | 63.59 | 12,488,630 |
| 2017-04-17 | Baddour Linda (Executive VP & CFO) | Option Ex | 196,393 | 7.33 | 1,440,542 |
| 2017-03-28 | Shannon Colin (President & CEO) | Sale | 50,000 | 64.00 | 3,200,000 |
| 2017-03-28 | Shannon Colin (President & CEO) | Option Ex | 50,000 | 2.94 | 147,000 |
| 2017-03-27 | Dockhorn David W (Executive Vice President & CCO) | Sale | 85,182 | 62.00 | 5,281,284 |
| 2017-03-27 | Dockhorn David W (Executive Vice President & CCO) | Option Ex | 85,182 | 7.33 | 624,809 |
| 2017-02-23 | Shannon Colin (President & CEO) | Sale | 97,253 | 61.50 | 5,981,059 |
| 2017-02-23 | Shannon Colin (President & CEO) | Option Ex | 97,253 | 2.94 | 285,923 |
| 2017-02-21 | Shannon Colin (President & CEO) | Sale | 2,747 | 61.50 | 168,940 |
| 2017-02-21 | Shannon Colin (President & CEO) | Option Ex | 2,747 | 2.94 | 8,076 |
| 2016-11-16 | Kkr North America Xi Ltd (10% Owner) | Sale | 7,500,000 | 55.51 | 416,325,000 |
| 2016-11-16 | Roberts George R (10% Owner) | Sale | 7,500,000 | 55.51 | 416,325,000 |
| 2016-08-22 | Shannon Colin (President & CEO) | Sale | 82,617 | 51.58 | 4,261,384 |
| 2016-08-19 | Shannon Colin (President & CEO) | Sale | 19,694 | 51.40 | 1,012,271 |
| 2016-08-18 | Shannon Colin (President & CEO) | Sale | 10,822 | 51.76 | 560,146 |
| 2016-08-18 | Shannon Colin (President & CEO) | Option Ex | 120,000 | 2.94 | 352,800 |
| 2016-08-15 | Baddour Linda (Executive VP & CFO) | Sale | 69,380 | 52.00 | 3,607,760 |
| 2016-08-15 | Baddour Linda (Executive VP & CFO) | Option Ex | 69,380 | 2.94 | 203,977 |
| 2016-08-12 | Dockhorn David W (Executive VP & CCO) | Sale | 107,257 | 49.00 | 5,255,593 |
| 2016-08-05 | Dockhorn David W (Executive VP & CCO) | Option Ex | 114,084 | 2.94 | 335,406 |
| 2016-05-06 | Baddour Linda (Executive VP & CFO) | Sale | 92,308 | 46.70 | 4,310,783 |
| 2016-05-06 | Roberts George R (10% Owner) | Sale | 4,907,692 | 46.70 | 229,189,216 |
| 2016-05-02 | Baddour Linda (Executive VP & CFO) | Option Ex | 92,308 | 2.94 | 271,385 |
| 2016-03-08 | Kkr North America Xi Ltd (10% Owner) | Sale | 4,829,981 | 42.26 | 204,114,997 |
| 2016-03-08 | Shannon Colin (President & CEO) | Sale | 77,019 | 42.26 | 3,254,822 |
| 2016-03-08 | Baddour Linda (Executive VP & CFO) | Sale | 93,000 | 42.26 | 3,930,180 |
| 2016-03-08 | Roberts George R (10% Owner) | Sale | 4,829,981 | 42.26 | 204,114,997 |
| 2016-03-02 | Shannon Colin (President & CEO) | Option Ex | 82,382 | 2.94 | 242,203 |
Insider trading activities including stock purchases, stock sales, and option exercises of PRAH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pra Health Sciences, Inc. (symbol PRAH, CIK number 1613859) see the Securities and Exchange Commission (SEC) website.